Silk Road Medical entered the Central Asian market in 2022 and is headquartered in Almaty, Kazakhstan. We are committed to discovering and curing diseases and improving lives through the power of science. At present, Silk Road Medical mainly focuses on experimental reagents, medical equipment, medical consumables, chemical and biological drugs, vaccines and other fields in Central Asia. Centered on patient needs, we collaborate with various sectors of society to actively promote the rapid development of health in Central Asia.